{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rare+Lesion",
    "query": {
      "condition": "Rare Lesion"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 1,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-05-22T02:00:33.232Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT03108131",
      "title": "Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Skin Squamous Cell Carcinoma",
        "Appendix Adenocarcinoma",
        "Rare Lesion",
        "Locally Advanced Malignant Neoplasm",
        "Locally Advanced Skin Squamous Cell Carcinoma",
        "Metastatic Malignant Neoplasm",
        "Metastatic Skin Squamous Cell Carcinoma",
        "Metastatic Small Intestinal Adenocarcinoma",
        "Rare Neoplastic Syndrome",
        "Refractory Malignant Neoplasm",
        "Stage IV Small Intestinal Adenocarcinoma AJCC v8",
        "Unresectable Malignant Neoplasm"
      ],
      "interventions": [
        {
          "name": "Atezolizumab",
          "type": "DRUG"
        },
        {
          "name": "Cobimetinib",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 49,
      "start_date": "2017-04-07",
      "completion_date": "2024-04-02",
      "has_results": true,
      "last_update_posted_date": "2025-05-28",
      "last_synced_at": "2026-05-22T02:00:33.232Z",
      "location_count": 1,
      "location_summary": "Houston, Texas",
      "locations": [
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03108131"
    }
  ]
}